http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-015557-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
filingDate 1999-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-015557-A1
titleOfInvention COMPOUNDS OF 1-ARIL-3-ARILMETIL-1,8-NAFTIRIDIN-4 (1H) -ONAS AND PHARMACEUTICAL COMPOSITION
abstract A compound of the formula (I) or the pharmaceutically acceptable salt thereof; in which one of R1 and R2 is independently selected from the group consisting of hydrogen, C1-6 alkyl, C3-7 cycloalkyl, C6-10 aryl, C5-9 heteroaryl and C2-9 erocycloalkyl group, where the alkyl, cycloalkyl groups , aryl, heteroaryl or heterocycloalkyl are optionally substituted with halo, hydroxy, C1-6 alkyl, C1-6 alkoxy, amino, C1-6 alkylamino, (C1-6 alkyl) 2-amino, thio, C1-6 alkylthio, cyan or , carboxy, carboxy-C 1-6 alkyl, hydroxy-C 1-6 alkyl, C 1-6 acyl, aminosulfonyl, C 1-6 alkylaminosulfonyl or (C 1-6 alkyl) 2-aminosulfonyl; and R3 is hydrogen, halo, hydroxy, C1-6 alkyl, C1-6 alkoxy, amino, C1-6 alkylamino, (C1-6 alkyl) 2-amino, thio, C1-6 alkylthio, carboxy, carboxy-C1-6 alkyl , hydroxy-C1-6 alkyl, acyl C1-6, aminosulfonyl, alkylaminosulfonyl C1-6 or (C1-6 alkyl) 2-aminosulfonyl, useful in the treatment of respiratory, allergic, rheumatoid, body weight regulation, inflammatory and of the central nervous system, such as asthma, chronic obstructive pulmonary disease, adult respiratory disease syndrome, toxic shock, fibrosis, pulmonary hypersensitivity, rhinitisallergic, dermatit is atopic, psoriasis, weight control, rheumatoid arthritis, cachexia, Crohn's disease, colitis ulcerative, arthritic conditions and other inflammatory diseases, depression, multi-infarct dementia and AIDS.
priorityDate 1998-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123

Total number of triples: 40.